Edward M. Kaye M.D., CEO at Stoke Therapeutics, Inc. (STOK), sold 13,572 shares at $12.99 ($176K) on 2024-12-09, disclosed to the SEC on 2024-12-11.
Open-market sale of $176k STOK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 6,786 | $88K | 50.0% |
| 2 | $12.99 | 6,786 | $88K | 50.0% |
| Total | $12.99 avg | 13,572 | $176K | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |